Sotera Health Announces Second-Quarter 2025 Earnings Release Date
Sotera Health (Nasdaq: SHC), a leading provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its second-quarter 2025 financial results release for August 8, 2025, before market open.
The company will host a conference call at 9:00 a.m. EDT to discuss results and operating highlights. Investors can participate via phone (US toll-free: 1-844-481-2916; International: 1-412-317-0709) or access the live webcast through the company's Investor Relations website. Conference materials will be available, and a webcast replay will be posted later that day.
[]Sotera Health (Nasdaq: SHC), un fornitore leader di soluzioni per la sterilizzazione e servizi di laboratorio per il settore sanitario, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per il 8 agosto 2025, prima dell'apertura dei mercati.
L'azienda terrà una conference call alle 9:00 EDT per discutere i risultati e i principali sviluppi operativi. Gli investitori potranno partecipare telefonicamente (numero verde USA: 1-844-481-2916; Internazionale: 1-412-317-0709) o seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori. I materiali della conference saranno disponibili e la registrazione della webcast sarà pubblicata più tardi nella stessa giornata.
Sotera Health (Nasdaq: SHC), un proveedor líder de soluciones de esterilización y servicios de laboratorio para la industria sanitaria, ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el 8 de agosto de 2025, antes de la apertura del mercado.
La compañía realizará una llamada conferencia a las 9:00 a.m. EDT para discutir los resultados y los aspectos destacados operativos. Los inversores podrán participar por teléfono (línea gratuita en EE.UU.: 1-844-481-2916; Internacional: 1-412-317-0709) o acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores. Los materiales de la conferencia estarán disponibles y la repetición de la transmisión se publicará más tarde ese mismo día.
Sotera Health (나스닥: SHC)는 의료 산업을 위한 멸균 솔루션 및 실험실 검사 서비스의 선도 업체로, 2025년 2분기 재무 실적 발표를 2025년 8월 8일 시장 개장 전으로 예정했습니다.
회사는 동부 표준시 오전 9시에 실적 및 운영 주요 사항을 논의하기 위한 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 전화(미국 무료: 1-844-481-2916; 국제: 1-412-317-0709)를 통해 참여하거나 회사 투자자 관계 웹사이트에서 생중계 웹캐스트에 접속할 수 있습니다. 컨퍼런스 자료가 제공되며, 웹캐스트 재방송은 같은 날 나중에 게시될 예정입니다.
Sotera Health (Nasdaq : SHC), un fournisseur de premier plan de solutions de stérilisation et de services de laboratoire pour le secteur de la santé, a programmé la publication de ses résultats financiers du deuxième trimestre 2025 pour le 8 août 2025, avant l'ouverture des marchés.
L'entreprise organisera une conférence téléphonique à 9h00 EDT pour discuter des résultats et des points forts opérationnels. Les investisseurs pourront participer par téléphone (numéro vert aux États-Unis : 1-844-481-2916 ; international : 1-412-317-0709) ou accéder au webcast en direct via le site des Relations Investisseurs. Les documents de la conférence seront disponibles et un replay du webcast sera mis en ligne plus tard dans la journée.
Sotera Health (Nasdaq: SHC), ein führender Anbieter von Sterilisationslösungen und Labortestdiensten für die Gesundheitsbranche, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 8. August 2025, vor Börsenöffnung, angekündigt.
Das Unternehmen wird um 9:00 Uhr EDT eine Telefonkonferenz abhalten, um die Ergebnisse und operative Highlights zu besprechen. Investoren können telefonisch teilnehmen (US gebührenfrei: 1-844-481-2916; international: 1-412-317-0709) oder den Live-Webcast über die Investor-Relations-Website des Unternehmens verfolgen. Konferenzunterlagen werden bereitgestellt und eine Webcast-Wiedergabe wird später am selben Tag veröffentlicht.
- None.
- None.
CLEVELAND, July 28, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the second-quarter ended June 30, 2025 before the market opens on Friday, August 8, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company’s financial results and operating highlights.
To participate in the live call, please dial 1-844-481-2916 (toll-free in the United States), or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call will be accessible at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available on the Company’s website later in the day on August 8th.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
| Contacts | |
| Jason Peterson Vice President, Investor Relations & Treasurer IR@soterahealth.com | |
| Kristin Gibbs Chief Marketing Officer, Sotera Health kgibbs@soterahealth.com |
Source: Sotera Health Company
FAQ
When will Sotera Health (SHC) release Q2 2025 earnings?
How can investors join Sotera Health's Q2 2025 earnings call?
Where can I find Sotera Health's Q2 2025 earnings presentation materials?
Will there be a replay of Sotera Health's Q2 2025 earnings call?
